Skip to content
OpenCapital
Get started

Alset Inc. AEI Biohealth Business — Operating Income

Other segment segments

Other
-$1.93M+13.5%
Real Estate
-$579.81K+43.7%
Digital Transformation Technology
-$49.39K+69.8%

Similar metrics at other companies

JAN
JANBiotech — Operating Income
-$177K+67.2%
Danaher logo
DHRBiotechnology — Operating Income (Loss)
$534M+21.1%
Comstock Inc. logo
LODEBioleum — Operating Income
-$5.64M-112%
AnaptysBio, Inc. logo
ANABBiopharma Company — Operating Income
-$52.81M-3.0%
Danaher logo
DHRLife Sciences — Operating Income (Loss)
$225M+11.9%
Addus HomeCare logo
ADUSHome Health — Operating Income
$3.16M+4.9%

Other financials

Income statement

See full
Revenue$980.8K-8.2%
Gross profit$275.1K-5.4%
Operating income-$2.7M+32.5%
Net income-$4.5M+45.7%
EPS (diluted)-$0.12+84.6%

Balance sheet

See full
Cash & equivalents$21.5M-14.7%
Total debt$1.3M-21.3%
Total equity$119.4M+56.4%
Total assets$131.7M+45.6%

Cash flow

See full
Operating cash flow-$1.5M+60.3%
CapEx$6.9K-88.8%
Free cash flow-$1.5M+60.8%

Valuation

See full
Market cap$56.01M+372%
Enterprise value$35.79M-340%
P/S12.8×+12.0×

Profitability

See full
Gross margin28.1%-16.6pp
Operating margin-316.4%—
Net margin-994.8%—
FCF margin27.8%—

Returns & leverage

See full
Return on equity-44.5%—
Debt / equity0×0.0×
Current ratio10.9×-0.3×

Where this comes from

Reported directly by Alset Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Alset Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alset Inc.'s biohealth business — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alset Inc.'s biohealth business — operating income?
Alset Inc. (AEI) reported biohealth business — operating income of -$97.62K in Q1 2026.
How has Alset Inc.'s biohealth business — operating income changed year-over-year?
Alset Inc.'s biohealth business — operating income increased by 81.0% year-over-year, from -$512.93K to -$97.62K.
What is the long-term trend for Alset Inc.'s biohealth business — operating income?
Over 2 years (2022 to 2025), Alset Inc.'s biohealth business — operating income has grown at a 54.4% compound annual growth rate (CAGR), from -$619.93K to -$1.48M.
What does biohealth business — operating income mean?
Measures the profitability of the biohealth segment by subtracting operating expenses from gross profit. It reflects the core operational performance of the segment before accounting for interest, taxes, or non-operating financial activities.